Core indicators of an evaluation and guidance system for quality of care in inflammatory bowel disease centers: A critical review - eClinicalMedicine
European Crohn´s and Colitis Organisation - ECCO - ECCO News
From single-target to cellular niche targeting in Crohn's disease: intercepting bad communications - eBioMedicine
ECCO IBD on the App Store
COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease
European Crohn´s and Colitis Organisation - ECCO - Home
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut
Medflixs - The 15th Congress of European Crohn's and Colitis Organisation, ECCO 2020
Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update
Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses - eClinicalMedicine
European Crohn´s and Colitis Organisation - ECCO - Who we are
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease - Rodríguez‐Lago - 2023 - United European Gastroenterology Journal - Wiley Online Library
ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease
ECCO GRADE Crohn's Disease (CD)Treatment Guidelines | efcca.org
ECCO IBD on the App Store
Ulcerative Colitis: Today, Tomorrow, and the Future - European Medical Journal
ECCO IBD on the App Store
European Crohn´s and Colitis Organisation - ECCO - ECCO e-Guide
Cureus | Use of Azathioprine in Ulcerative Colitis: A Comprehensive Review | Article
ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease
Frontiers | Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
PredictImmune Ltd on Twitter: "#ThrowbackThursday to our poster from ECCO 2020, which details our health economic analysis showing how @PredictSUREIBD offers a cost-effective way to help doctors choose the right treatment for
Management of IBD during the COVID-19 outbreak: resetting clinical priorities | Nature Reviews Gastroenterology & Hepatology
ECCO 2022
Journal of Crohn's and Colitis | ScienceDirect.com by Elsevier
Gastroenterology Insights | Free Full-Text | Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What's New?
European Crohn´s and Colitis Organisation - ECCO - Editor's choice: the ECCO IBD App
